PPP Stock Overview
Engages in the production, sale, and distribution of medicines primarily in Vietnam. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Phong Phu Pharmaceutical Joint Stock Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₫18,000.00 |
52 Week High | ₫20,600.00 |
52 Week Low | ₫14,100.00 |
Beta | 0.19 |
11 Month Change | 5.88% |
3 Month Change | 5.88% |
1 Year Change | 11.80% |
33 Year Change | 5.88% |
5 Year Change | 25.87% |
Change since IPO | 88.57% |
Recent News & Updates
Recent updates
Shareholder Returns
PPP | VN Pharmaceuticals | VN Market | |
---|---|---|---|
7D | 0% | 0.1% | -2.3% |
1Y | 11.8% | 19.4% | 7.2% |
Return vs Industry: PPP underperformed the VN Pharmaceuticals industry which returned 19.4% over the past year.
Return vs Market: PPP exceeded the VN Market which returned 7.2% over the past year.
Price Volatility
PPP volatility | |
---|---|
PPP Average Weekly Movement | 4.9% |
Pharmaceuticals Industry Average Movement | 3.4% |
Market Average Movement | 3.4% |
10% most volatile stocks in VN Market | 6.5% |
10% least volatile stocks in VN Market | 1.8% |
Stable Share Price: PPP's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: PPP's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | n/a | n/a | duocphongphu.vn |
Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals.
Phong Phu Pharmaceutical Joint Stock Company Fundamentals Summary
PPP fundamental statistics | |
---|---|
Market cap | ₫158.40b |
Earnings (TTM) | ₫17.51b |
Revenue (TTM) | ₫140.80b |
9.0x
P/E Ratio1.1x
P/S RatioIs PPP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PPP income statement (TTM) | |
---|---|
Revenue | ₫140.80b |
Cost of Revenue | ₫94.36b |
Gross Profit | ₫46.43b |
Other Expenses | ₫28.92b |
Earnings | ₫17.51b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.99k |
Gross Margin | 32.98% |
Net Profit Margin | 12.44% |
Debt/Equity Ratio | 0% |
How did PPP perform over the long term?
See historical performance and comparison